Literature DB >> 19123738

Micropapillary variant of urothelial carcinoma in the upper urinary tract: a clinicopathologic study of 11 cases.

Charles C Guo1, Pheroze Tamboli, Bogdan Czerniak.   

Abstract

CONTEXT: Micropapillary urothelial carcinoma (MPUC) is a rare variant of urothelial carcinoma. Most studies of MPUC have focused on the urinary bladder, but MPUC of the upper urinary tract remains to be investigated.
OBJECTIVE: To investigate the pathologic features and clinical significance of MPUC in the upper urinary tract.
DESIGN: We searched the pathology files at our institution and identified 11 cases of MPUC of the upper urinary tract. The histology slides were reviewed, and the clinical information was obtained by review of medical charts.
RESULTS: The average age of the patients was 64.2 years (range, 22-76 years). The tumors were located in the renal pelvis (n = 5), ureter (n = 4), and ureteropelvic junction (n = 2). In all cases, MPUC accounted for an average of 45% (range, 10%-80%) of the tumor and was associated with conventional urothelial carcinoma. Lymphovascular invasion was present in all cases, and metastasis to lymph node was present in 4 of 5 patients whose lymph nodes were dissected. Two patients presented with pT2 disease, and both were alive without evidence of disease at 85 and 119 months after surgery. The other 9 patients presented with pT3 or pT4 disease: 4 of them died of disease at an average of 18 months; 4 surviving patients developed distant metastases; and 1 surviving patient with limited follow-up (6 months) showed no evidence of disease.
CONCLUSIONS: Micropapillary urothelial carcinoma of the upper urinary tract often presents at an advanced stage with lymphovascular invasion and distant metastasis. The presence of MPUC, even focal, indicates a poor clinical course.

Entities:  

Mesh:

Year:  2009        PMID: 19123738     DOI: 10.5858/133.1.62

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

1.  Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinoma.

Authors:  Jonathan J Duplisea; Firas G Petros; Roger Li; Bryan Fellman; Charles C Guo; Bogdan A Czerniak; Arlene O Siefker-Radtke; John C Araujo; Colin P N Dinney; Surena F Matin
Journal:  Urol Oncol       Date:  2019-02-16       Impact factor: 3.498

2.  Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Alexandra Masson-Lecomte; Pierre Colin; Gregory Bozzini; Laurent Nison; Alexandre de La Taille; Eva Comperat; Marc Zerbib; François Rozet; Xavier Cathelineau; Antoine Valeri; Alain Ruffion; Laurent Guy; Stéphane Droupy; Olivier Cussenot; Morgan Rouprêt
Journal:  World J Urol       Date:  2013-08-02       Impact factor: 4.226

Review 3.  Perioperative chemotherapy for upper tract urothelial cancer.

Authors:  Ajjai S Alva; Surena F Matin; Seth P Lerner; Arlene O Siefker-Radtke
Journal:  Nat Rev Urol       Date:  2012-04-10       Impact factor: 14.432

4.  Pulmonary metastasis in a patient with simultaneous bladder cancer and relapsing granulomatosis with polyangiitis.

Authors:  Mauricio Danckers; Fang Zhou; Diana Nimeh; H Michael Belmont; David J Steiger
Journal:  Am J Case Rep       Date:  2015-05-14

Review 5.  Current Knowledge on Genomic Profiling of Upper Tract Urothelial Carcinoma.

Authors:  Elisa De Lorenzis; Giancarlo Albo; Fabrizio Longo; Carolina Bebi; Luca Boeri; Emanuele Montanari
Journal:  Genes (Basel)       Date:  2021-02-25       Impact factor: 4.096

6.  Micropapillary urothelial carcinoma: Cytologic features in a retrospective series of urine specimens.

Authors:  Jonas John Heymann; Anjali Saqi; Andrew Thomas Turk; John Crapanzano
Journal:  Cytojournal       Date:  2013-02-28       Impact factor: 2.091

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.